Savant Capital LLC Has $3.98 Million Holdings in Ingevity Co. (NYSE:NGVT)

Savant Capital LLC lifted its position in shares of Ingevity Co. (NYSE:NGVT) by 0.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,327 shares of the company’s stock after purchasing an additional 342 shares during the quarter. Savant Capital LLC’s holdings in Ingevity were worth $3,982,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. Wellington Management Group LLP lifted its holdings in shares of Ingevity by 3.7% in the third quarter. Wellington Management Group LLP now owns 2,067,523 shares of the company’s stock valued at $98,435,000 after purchasing an additional 73,412 shares in the last quarter. Victory Capital Management Inc. raised its position in Ingevity by 2.7% in the 3rd quarter. Victory Capital Management Inc. now owns 1,176,836 shares of the company’s stock valued at $56,029,000 after buying an additional 30,632 shares during the last quarter. Brown Advisory Inc. lifted its stake in Ingevity by 2.8% during the 3rd quarter. Brown Advisory Inc. now owns 741,755 shares of the company’s stock valued at $35,315,000 after acquiring an additional 20,376 shares in the last quarter. American Century Companies Inc. boosted its holdings in Ingevity by 14.4% during the 3rd quarter. American Century Companies Inc. now owns 494,464 shares of the company’s stock worth $23,541,000 after acquiring an additional 62,418 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Ingevity by 6.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 439,066 shares of the company’s stock worth $20,904,000 after acquiring an additional 25,550 shares in the last quarter. 91.59% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

NGVT has been the topic of a number of recent analyst reports. Jefferies Financial Group raised shares of Ingevity from a “hold” rating to a “buy” rating and raised their price target for the company from $52.00 to $62.00 in a research report on Monday, April 22nd. Wells Fargo & Company increased their price objective on shares of Ingevity from $43.00 to $50.00 and gave the company an “equal weight” rating in a research note on Friday, February 23rd. Five equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $51.40.

Ingevity Stock Up 1.4 %

Shares of NYSE:NGVT opened at $51.87 on Thursday. Ingevity Co. has a fifty-two week low of $36.66 and a fifty-two week high of $72.41. The company’s 50-day moving average is $46.75 and its 200 day moving average is $44.00. The company has a debt-to-equity ratio of 2.19, a current ratio of 1.81 and a quick ratio of 0.96.

Ingevity (NYSE:NGVT) last released its earnings results on Wednesday, February 21st. The company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.34. Ingevity had a negative net margin of 0.32% and a positive return on equity of 20.75%. The firm had revenue of $371.70 million for the quarter, compared to analysts’ expectations of $336.74 million. During the same period in the previous year, the company earned $0.57 earnings per share. The company’s quarterly revenue was down 3.1% on a year-over-year basis. Equities analysts forecast that Ingevity Co. will post 3.69 EPS for the current fiscal year.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.